Viridian Therapeutics, Inc. (VRDN)
Total Valuation
VRDN has a market cap or net worth of $409.25 million. The enterprise value is $195.44 million.
| Market Cap | 409.25M |
| Enterprise Value | 195.44M |
Important Dates
The latest earnings date was Monday, November 8, 2021 after market close.
| Last Earnings Date | Nov 8, 2021 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 21.72 million shares outstanding. The number of shares has increased by 200.70% in one year.
| Shares Outstanding | 21.72M |
| Shares Change (YoY) | +200.70% |
| Shares Change (QoQ) | +37.95% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 92.80% |
| Float | 9.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 146.00 |
| PB Ratio | 2.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
| EV / Earnings | n/a |
| EV / Sales | 69.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 15.20 |
| Quick Ratio | 14.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | -106.70% |
| Return on Assets (ROA) | -95.20% |
| Return on Capital (ROIC) | -204.20% |
| Revenue Per Employee | $107,808 |
| Profits Per Employee | -$5.43M |
| Employee Count | 26 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.92% in the last 52 weeks. The beta is 1.10, so VRDN's price volatility has been similar to the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | -11.92% |
| 50-Day Moving Average | 18.24 |
| 200-Day Moving Average | 16.31 |
| Average Volume (30 Days) | 229,871 |
Short Selling Information
| Short Interest | 141,479 |
| Short % of Shares Out | 0.65% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, VRDN had revenue of $2.80 million and -$141.21 million in losses. Earnings per share was -$19.21.
| Revenue | 2.80M |
| Gross Profit | 2.80M |
| Operating Income | -141.25M |
| Net Income | -141.21M |
| EBITDA | -140.89M |
| EBIT | -141.03M |
| Earnings Per Share (EPS) | -$19.21 |
Balance Sheet
| Cash & Cash Equivalents | 213.81M |
| Total Debt | n/a |
| Net Cash | 213.81M |
| Net Cash Per Share | $9.84 |
| Book Value | 204.59M |
| Book Value Per Share | 9.42 |
| Working Capital | 203.60M |
Cash Flow
In the last 12 months, operating cash flow was -$47.48 million and capital expenditures -$167,000, giving a free cash flow of -$47.65 million.
| Operating Cash Flow | -47.48M |
| Capital Expenditures | -167,000 |
| Free Cash Flow | -47.65M |
| FCF Per Share | -$2.19 |
Margins
Gross margin is 100.00%, with operating and profit margins of -5,039.07% and -5,037.78%.
| Gross Margin | 100.00% |
| Operating Margin | -5,039.07% |
| Pretax Margin | n/a |
| Profit Margin | -5,037.78% |
| EBITDA Margin | -5,026.44% |
| EBIT Margin | -5,031.36% |
| FCF Margin | -1,699.93% |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -34.50% |
| FCF Yield | -11.64% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |